Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 152 recruiting now full pipeline #8 of 28,963 conditions

Hypertension: full-pipeline trial registry

152 of 472 indexed Hypertension trials are currently recruiting.

Corpus placement: #8 of 28,963 conditions by registered trial count.

472 US clinical trials · 152 currently recruiting · #8 of 28,963 conditions by registered trial count

Hypertension: 472 US clinical trials tracked, 152 recruiting.

Hypertension is the subject of 472 registered US clinical trials on ClinicalTrials.gov, 152 of them currently open to new participants. 65 are in Phase 3-4 (later-stage) and 64 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 15 of these trials.

Open enrollment snapshot

Hypertension has 472 registered US clinical trials, 152 of them open to new participants right now, about 32% of the total.

152
recruiting participants now
32%
of trials open to enrollment
65
in Phase 3-4 (later-stage)
15
top sponsor: Johns Hopkins University

Corpus placement: #8 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Hypertension on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Hypertension is recruiting below its size-band peers.

    152 of 472 indexed trials (32.2%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Hypertension trials is spread across many organizations.

    Johns Hopkins University accounts for 15 of 472 trials (3.2%). 195 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hypertension enrolment sits around 168 participants.

    Median target enrolment is 168 among the 471 trials that report a genuine target (sentinel values excluded). 170 of those (36.1%) plan for fewer than 100 participants.

  4. Hypertension research is mostly interventional.

    407 interventional and 65 observational studies make up this index (86.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 139Phase 225Phase 337Phase 428

Open and recent trials

472 total, page 8 of 10

COMPLETED NA 118 participants

Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention

Wayne State University

NCT01052220

COMPLETED NA 116 participants

Best Rest: Rest Time Before Blood Pressure Measurement Trial

Johns Hopkins University

NCT04031768

COMPLETED NA 112 participants

Nitric Oxide and the Autonomic Nervous System

Vanderbilt University

NCT00178919

COMPLETED 112 participants

Improving Outcomes for Hypertensive Children

Arkansas Children's Hospital Research Institute

NCT01485783

COMPLETED NA 111 participants

Interactive Spaced Education to Optimize Hypertension Management

VA Office of Research and Development

NCT00904007

COMPLETED Phase 4 110 participants

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

Daiichi Sankyo

NCT00185068

COMPLETED Phase 2 110 participants

A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension

Mylan Bertek Pharmaceuticals

NCT00200421

COMPLETED 109 participants

Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals

Baxter Healthcare Corporation

NCT02337790

COMPLETED NA 108 participants

Using Health Information Technology (HIT) to Improve Ambulatory Chronic Disease Care: Smart Device Substudy

University of Missouri-Columbia

NCT00802152

COMPLETED 108 participants

Racial Differences in Control of Blood Vessel Tone and Blood Flow

National Heart, Lung, and Blood Institute (NHLBI)

NCT00001747

COMPLETED 106 participants

52-104 Week Off-therapy Second Extension to Study CSPP100A2365

Noden Pharma

NCT01420068

COMPLETED NA 105 participants

Dietary Approaches to Stop Hypertension for Diabetes

Johns Hopkins University

NCT04286555

COMPLETED NA 104 participants

REACH OUT: to Reduce High Blood Pressure in the Emergency Department

University of Michigan

NCT02301455

COMPLETED NA 102 participants

Effects of Omega-3 Fatty Acids on Markers of Inflammation

Stanford University

NCT01129050

COMPLETED Phase 3 100 participants

307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects

AstraZeneca

NCT00255502

COMPLETED 100 participants

Intraoperative Blood Pressure and Cognitive Performance

Weill Medical College of Cornell University

NCT00827385

COMPLETED NA 100 participants

Randomized Trial to Evaluate the Effectiveness of Nurse Case Management

Johns Hopkins University

NCT00295256

COMPLETED Phase 4 96 participants

Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells

Emory University

NCT01041287

COMPLETED Phase 3 95 participants

Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age

AstraZeneca

NCT00244621

COMPLETED NA 90 participants

"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"

University of Wisconsin, Madison

NCT01317329

COMPLETED Phase 1 87 participants

Study of the Response of Human Small Blood Vessels

National Heart, Lung, and Blood Institute (NHLBI)

NCT00001622

COMPLETED NA 85 participants

A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations

Johns Hopkins University

NCT04696653

COMPLETED NA 85 participants

Lifelight Non-Invasive Blood Pressure and Heart Rate Validation Study

Xim Limited

NCT06535152

COMPLETED Phase 2 85 participants

Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

University of Texas Southwestern Medical Center

NCT03354143

COMPLETED NA 75 participants

Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support

Amanda Shallcross

NCT06460272

COMPLETED NA 75 participants

Way to Health, Healthy Measures

University of Pennsylvania

NCT01282957

COMPLETED NA 75 participants

Improving Blood Pressure Control Among Food Insecure Hypertensive Adults

University of Florida

NCT05877898

COMPLETED Phase 4 75 participants

The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

Vanderbilt University

NCT00872599

COMPLETED NA 75 participants

Understanding the Exercise-Hypertension Paradox

VA Office of Research and Development

NCT02034422

COMPLETED NA 75 participants

Feasibility of Integrating Indirect Calorimetry (IC) Technology in Primary Care

Colorado Center for Chronic Care Innovations

NCT00750022

COMPLETED Phase 1 72 participants

Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules

Pfizer

NCT04967443

COMPLETED NA 71 participants

Evaluation of a Lifestyle Medicine Practice

Ohio University

NCT03739034

COMPLETED NA 70 participants

Food as Medicine: A Quasi-Randomized Control Trial of Healthy Foods for Chronic Disease Management

Cleveland Clinic Akron General

NCT05174078

COMPLETED NA 70 participants

Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study

Medical University of South Carolina

NCT02167464

COMPLETED NA 66 participants

Exercise in Pregnancy for Reduction of Blood Pressure in Obese Patients

Milton S. Hershey Medical Center

NCT01261884

COMPLETED Phase 1 65 participants

Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood Pressure

National Center for Complementary and Integrative Health (NCCIH)

NCT00099476

COMPLETED NA 63 participants

Activity Trackers for Improving BP

University of California, San Francisco

NCT03325426

COMPLETED NA 63 participants

Comorbidities And Reducing inEquitieS

Medstar Health Research Institute

NCT04836221

COMPLETED NA 62 participants

Walk Together: A Family-Based Intervention for Hypertension In African Americans

University of Texas Southwestern Medical Center

NCT05671302

COMPLETED NA 60 participants

The Penn Lifestyle Modification and Blood Pressure Study

University of Pennsylvania

NCT00328666

COMPLETED Phase 4 60 participants

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Daiichi Sankyo

NCT00185094

COMPLETED NA 60 participants

Improving Hypertension Control

Medical College of Wisconsin

NCT01910857

COMPLETED 60 participants

Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study

Weill Medical College of Cornell University

NCT00227175

COMPLETED NA 60 participants

Trial to Address Food Insecurity in Patients With Hypertension (SMART-FI)

Wake Forest University Health Sciences

NCT05800145

COMPLETED Phase 1 60 participants

Antihypertensive Treatment in Acute Cerebral Hemorrhage

University of Minnesota

NCT00415610

COMPLETED NA 60 participants

Behavioral Economics to Improve Antihypertensive Therapy Adherence

Cedars-Sinai Medical Center

NCT04029883

COMPLETED Phase 2 58 participants

Biomarker Guided Therapies in Stage A/B Heart Failure

VA Office of Research and Development

NCT02230891

COMPLETED NA 56 participants

A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch

The Cleveland Clinic

NCT03986281

COMPLETED NA 56 participants

Mindfulness Based Stress Reduction for High Blood Pressure

Kent State University

NCT00440596

COMPLETED NA 55 participants

Insights for Community Health

NYU Langone Health

NCT01681862

← Previous Page 8 of 10 Next →

Phase Distribution

PhaseTrial count
Phase 1 39
Phase 2 25
Phase 3 37
Phase 4 28

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Hypertension right now

152 recruiting of 472 indexed (32% open).

Phase mix: 65 late (III/IV) vs 64 early (I/II) (balanced across stages).

Top sponsor: Johns Hopkins University (15 trials), 9 others listed. 50 shown below, recruiting first. #8 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Hypertension?

PlainTrial tracks 472 US clinical trials for Hypertension, of which 152 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Hypertension?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.